Market Cap 402.03M
Revenue (ttm) 0.00
Net Income (ttm) -165.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 684,200
Avg Vol 1,810,362
Day's Range N/A - N/A
Shares Out 103.88M
Stochastic %K 13%
Beta 0.74
Analysts Strong Sell
Price Target $14.30

Company Profile

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Industry: Biotechnology
Sector: Healthcare
Phone: 844 511 9056
Address:
Three Bala Plaza East, Suite 506, Bala Cynwyd, United States
nopennys
nopennys Sep. 3 at 8:08 PM
$LRMR they are trying to frustrate the impatient. Keep adding. One fine day it will be buy out
0 · Reply
Rastaman2112
Rastaman2112 Sep. 2 at 11:47 AM
$LRMR Just need $6 buy december
0 · Reply
ashley67687
ashley67687 Sep. 2 at 10:39 AM
$LRMR some fine day I will awake to the price of $LRMR exploding upwards. Until then, patience grasshopper
0 · Reply
ashley67687
ashley67687 Sep. 1 at 11:33 PM
$LRMR typical small biotech price action. They move when significant news is released.
0 · Reply
tiddyy
tiddyy Aug. 31 at 9:03 PM
$LRMR What’s up with this?
1 · Reply
OldManLogan
OldManLogan Aug. 31 at 7:11 PM
$LRMR Phase 3 starts within a month, other modules submitted probably a month after that... FDA submission acceptance less than a month after that... pieces falling into place soon...
0 · Reply
ashley67687
ashley67687 Aug. 31 at 5:56 PM
$LRMR buying more down here. Thanks for the cheap shares
0 · Reply
ddxrich
ddxrich Aug. 26 at 9:52 PM
$LRMR Don't understand why it gets smacked at the open and then has to claw back all day. Can we just get some decent gains already 🙏
0 · Reply
ronaldo7
ronaldo7 Aug. 26 at 12:55 PM
$TNXP $LRMR I am glad I own these two stocks……
0 · Reply
kenny91655
kenny91655 Aug. 26 at 11:48 AM
$LRMR I think we could see a moment of under 4 again today.
0 · Reply
Latest News on LRMR
Larimar Therapeutics reports Q2 EPS (30c), consensus (38c)

2026-08-04T11:50:32.000Z - 4 weeks ago

Larimar Therapeutics reports Q2 EPS (30c), consensus (38c)


Larimar Therapeutics Earnings release: Q2 2026

Aug 4, 2026, 7:00 AM EDT - 4 weeks ago

Larimar Therapeutics Earnings release: Q2 2026


Larimar Therapeutics Quarterly report: Q2 2026

Aug 4, 2026, 7:00 AM EDT - 4 weeks ago

Larimar Therapeutics Quarterly report: Q2 2026


Larimar Therapeutics Slides: Corporate presentation

Aug 3, 2026, 7:00 AM EDT - 4 weeks ago

Larimar Therapeutics Slides: Corporate presentation


Larimar Therapeutics director buys $167K in common stock

2026-07-08T20:10:11.000Z - 1 month ago

Larimar Therapeutics director buys $167K in common stock


Larimar Therapeutics assumed with a Buy at H.C. Wainwright

2026-07-02T10:05:18.000Z - 2 months ago

Larimar Therapeutics assumed with a Buy at H.C. Wainwright


Larimar Therapeutics selloff a buying opportunity, says Citi

2026-06-30T09:55:21.000Z - 2 months ago

Larimar Therapeutics selloff a buying opportunity, says Citi


Larimar Therapeutics Transcript: Study update

Jun 29, 2026, 7:45 AM EDT - 2 months ago

Larimar Therapeutics Transcript: Study update


Larimar Therapeutics Press release: Study update

Jun 29, 2026, 7:45 AM EDT - 2 months ago

Larimar Therapeutics Press release: Study update


Larimar Therapeutics Slides: Study update

Jun 29, 2026, 7:45 AM EDT - 2 months ago

Larimar Therapeutics Slides: Study update


Larimar Therapeutics initiated with an Overweight at JPMorgan

2026-05-27T09:15:57.000Z - 3 months ago

Larimar Therapeutics initiated with an Overweight at JPMorgan


Larimar Therapeutics reports Q1 EPS (31c), consensus (57c)

2026-05-14T13:05:57.000Z - 3 months ago

Larimar Therapeutics reports Q1 EPS (31c), consensus (57c)


Larimar Therapeutics Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Larimar Therapeutics Earnings release: Q1 2026


Larimar Therapeutics Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Larimar Therapeutics Quarterly report: Q1 2026


Larimar Therapeutics Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 3 months ago

Larimar Therapeutics Slides: Corporate presentation


Larimar Therapeutics Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 4 months ago

Larimar Therapeutics Proxy statement: Proxy filing


Larimar Therapeutics Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 4 months ago

Larimar Therapeutics Proxy statement: Proxy filing


Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)

2026-03-19T11:21:35.000Z - 5 months ago

Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)


Larimar Therapeutics Annual report: Q4 2025

Mar 19, 2026, 7:00 AM EDT - 5 months ago

Larimar Therapeutics Annual report: Q4 2025


Larimar Therapeutics Earnings release: Q4 2025

Mar 19, 2026, 7:00 AM EDT - 5 months ago

Larimar Therapeutics Earnings release: Q4 2025


Larimar Therapeutics Slides: Corporate presentation

Mar 10, 2026, 7:00 AM EDT - 5 months ago

Larimar Therapeutics Slides: Corporate presentation


Larimar Therapeutics 20M share Spot Secondary priced at $5.00

2026-02-26T02:10:10.000Z - 6 months ago

Larimar Therapeutics 20M share Spot Secondary priced at $5.00


Larimar Therapeutics Slides: Corporate presentation

Jan 8, 2026, 7:00 AM EST - 7 months ago

Larimar Therapeutics Slides: Corporate presentation


Larimar Therapeutics Quarterly report: Q3 2025

Nov 5, 2025, 7:00 AM EST - 10 months ago

Larimar Therapeutics Quarterly report: Q3 2025


Larimar Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 7:00 AM EST - 10 months ago

Larimar Therapeutics Earnings release: Q3 2025


Larimar Therapeutics Transcript: Study Update

Sep 29, 2025, 8:00 AM EDT - 11 months ago

Larimar Therapeutics Transcript: Study Update


Larimar Therapeutics Press release: Study Update

Sep 29, 2025, 8:00 AM EDT - 11 months ago

Larimar Therapeutics Press release: Study Update


Larimar Therapeutics Slides: Study Update

Sep 29, 2025, 8:00 AM EDT - 11 months ago

Larimar Therapeutics Slides: Study Update


Larimar Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Quarterly report: Q2 2025


Larimar Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Earnings release: Q2 2025


Larimar Therapeutics Transcript: Status Update

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Larimar Therapeutics Transcript: Status Update


Larimar Therapeutics Press release: Status Update

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Larimar Therapeutics Press release: Status Update


Larimar Therapeutics Slides: Status Update

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Larimar Therapeutics Slides: Status Update


Larimar Therapeutics Slides: Corporate Presentation

Jun 23, 2025, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Slides: Corporate Presentation


Larimar Therapeutics Quarterly report: Q1 2025

Apr 30, 2025, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Quarterly report: Q1 2025


Larimar Therapeutics Earnings release: Q1 2025

Apr 30, 2025, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Earnings release: Q1 2025


Larimar Therapeutics Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Larimar Therapeutics Proxy statement: Proxy Filing


Larimar Therapeutics Annual report: Q4 2024

Mar 24, 2025, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Annual report: Q4 2024


Larimar Therapeutics Earnings release: Q4 2024

Mar 24, 2025, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Earnings release: Q4 2024


Larimar Therapeutics Transcript: Study Update

Dec 16, 2024, 8:00 AM EST - 1 year ago

Larimar Therapeutics Transcript: Study Update


Larimar Therapeutics Press release: Study Update

Dec 16, 2024, 8:00 AM EST - 1 year ago

Larimar Therapeutics Press release: Study Update


Larimar Therapeutics Slides: Study Update

Dec 16, 2024, 8:00 AM EST - 1 year ago

Larimar Therapeutics Slides: Study Update


Larimar Therapeutics Slides: Corporate Presentation

Oct 30, 2024, 7:30 AM EDT - 1 year ago

Larimar Therapeutics Slides: Corporate Presentation


Larimar Therapeutics Quarterly report: Q3 2024

Oct 30, 2024, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Quarterly report: Q3 2024


Larimar Therapeutics Earnings release: Q3 2024

Oct 30, 2024, 7:00 AM EDT - 1 year ago

Larimar Therapeutics Earnings release: Q3 2024


Larimar Therapeutics Quarterly report: Q2 2024

Aug 7, 2024, 7:00 AM EDT - 2 years ago

Larimar Therapeutics Quarterly report: Q2 2024


Larimar Therapeutics Earnings release: Q2 2024

Aug 7, 2024, 7:00 AM EDT - 2 years ago

Larimar Therapeutics Earnings release: Q2 2024


Larimar Therapeutics Quarterly report: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

Larimar Therapeutics Quarterly report: Q1 2024


Larimar Therapeutics Earnings release: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

Larimar Therapeutics Earnings release: Q1 2024


Larimar Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Larimar Therapeutics Proxy statement: Proxy Filing


Larimar Therapeutics Proxy statement: Proxy Filing

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Larimar Therapeutics Proxy statement: Proxy Filing


Larimar Therapeutics Earnings release: Q4 2023

Mar 14, 2024, 12:00 PM EDT - 2 years ago

Larimar Therapeutics Earnings release: Q4 2023


Larimar Therapeutics Annual report: Q4 2023

Mar 14, 2024, 12:00 PM EDT - 2 years ago

Larimar Therapeutics Annual report: Q4 2023


Larimar Therapeutics Quarterly report: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Larimar Therapeutics Quarterly report: Q3 2023


Larimar Therapeutics Earnings release: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Larimar Therapeutics Earnings release: Q3 2023


Larimar Therapeutics Quarterly report: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Larimar Therapeutics Quarterly report: Q2 2023


Larimar Therapeutics Earnings release: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Larimar Therapeutics Earnings release: Q2 2023


Larimar Therapeutics Set to Join Russell 3000® Index

Jun 21, 2023, 4:05 PM EDT - 3 years ago

Larimar Therapeutics Set to Join Russell 3000® Index


Larimar Therapeutics Quarterly report: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Larimar Therapeutics Quarterly report: Q1 2023


Larimar Therapeutics Earnings release: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Larimar Therapeutics Earnings release: Q1 2023


nopennys
nopennys Sep. 3 at 8:08 PM
$LRMR they are trying to frustrate the impatient. Keep adding. One fine day it will be buy out
0 · Reply
Rastaman2112
Rastaman2112 Sep. 2 at 11:47 AM
$LRMR Just need $6 buy december
0 · Reply
ashley67687
ashley67687 Sep. 2 at 10:39 AM
$LRMR some fine day I will awake to the price of $LRMR exploding upwards. Until then, patience grasshopper
0 · Reply
ashley67687
ashley67687 Sep. 1 at 11:33 PM
$LRMR typical small biotech price action. They move when significant news is released.
0 · Reply
tiddyy
tiddyy Aug. 31 at 9:03 PM
$LRMR What’s up with this?
1 · Reply
OldManLogan
OldManLogan Aug. 31 at 7:11 PM
$LRMR Phase 3 starts within a month, other modules submitted probably a month after that... FDA submission acceptance less than a month after that... pieces falling into place soon...
0 · Reply
ashley67687
ashley67687 Aug. 31 at 5:56 PM
$LRMR buying more down here. Thanks for the cheap shares
0 · Reply
ddxrich
ddxrich Aug. 26 at 9:52 PM
$LRMR Don't understand why it gets smacked at the open and then has to claw back all day. Can we just get some decent gains already 🙏
0 · Reply
ronaldo7
ronaldo7 Aug. 26 at 12:55 PM
$TNXP $LRMR I am glad I own these two stocks……
0 · Reply
kenny91655
kenny91655 Aug. 26 at 11:48 AM
$LRMR I think we could see a moment of under 4 again today.
0 · Reply
Freddieee
Freddieee Aug. 26 at 11:45 AM
$LRMR guys any suggestion about forecast, possible price target etc? Thx 🙏
1 · Reply
OldManLogan
OldManLogan Aug. 25 at 3:38 PM
$LRMR It's funny... the shorts are really in a pickle here... how do they cover a 12% short position when only around 2-4% available that isn't owned by either tutes or insiders... so they try to do wacky things like bouncing the SP around to try to stoke retailers fears a little (evidently not working) and other goofy things like trying to play with the 'sentiment score' ... Twits shows a very bearish sentiment even though there hasn't been a single bearish comment here in over a month, lol. When the shorts finally figure the math out, they'll realize the best exit strategy is to cover ASAP... Time to wake up, shorts.
0 · Reply
OldManLogan
OldManLogan Aug. 20 at 4:39 PM
$LRMR Larimar by the numbers: Global P3 study expected to commence within the next month. All modules submitted to FDA anytime within 3 months. FDA acceptance before YE (or within 4 months). Possible other cataylsts that aren't on people's radar as well. Meanwhile, 95% of shares held by institutions. Somewhere between 1-4% owned by insiders... yet 12% Short Interest... HMM! Next few months is the end game for shorts and they don't have any exit strategy other than pleading with tutes to please sell them some shares, lol. There is nowhere near enough call volume to cover SI. Will be interesting to see how it plays out... could lead to much bigger spikes on catalysts news than would otherwise be anticipated...
0 · Reply
BiotechStockFundManager
BiotechStockFundManager Aug. 20 at 2:24 PM
$LRMR Low volume today. This will bounce back in the next day or two.
0 · Reply
jsmerka
jsmerka Aug. 19 at 9:48 PM
$LRMR 4.40 is inevitable inevitable
0 · Reply
OldManLogan
OldManLogan Aug. 19 at 1:44 PM
$LRMR Good timing!
1 · Reply
Jamieraffle
Jamieraffle Aug. 19 at 1:44 PM
$LRMR and she bites back good 😅😉
0 · Reply
MysticChartReaderIQ69
MysticChartReaderIQ69 Aug. 18 at 10:26 PM
$LRMR I’m a buyer here
0 · Reply
Jamieraffle
Jamieraffle Aug. 18 at 3:50 PM
$LRMR ouch 😑
0 · Reply
tiddyy
tiddyy Aug. 18 at 5:19 AM
$LRMR Dang this $4.4 resistance got hands
0 · Reply
OldManLogan
OldManLogan Aug. 17 at 3:15 PM
$LRMR Draw a line through the uptrend that started at the beginning of July... this will be in the $5S in September... after that it's anybody's guess as the catalysts of the completed submission to the FDA and then FDA acceptance followed by the 6 month countdown are all happening between now and year end...
0 · Reply
OldManLogan
OldManLogan Aug. 14 at 4:10 AM
$LRMR Just quietly buying any dips...
0 · Reply